CNN Money - The FDA has grown increasingly cautious about drug safety, after Merck & Co. (down $0.34 to $49.78, Charts , Fortune 500 ) pulled its FDA-approved anti-arthritis painkiller Vioxx off the market in 2004 because of links to heart attacks and strokes. Dr Read More
CNET News - Surely no […]

Daniels subpoenaed in Vioxx lawsuitIndianapolis Star, United States - Jul 26, 2007Thousands of federal Vioxx cases are before US District Judge Eldon Fallon, who was assigned to handle pretrial litigation for them. …
Read More…

Vioxx Trials May Focus on Stroke VictimsTherapeutics Daily (subscription) (press release), PA - Jul 29, 200729, 2007 NEW ORLEANS_Next year's federal Vioxx trials may focus […]

Hearing in New Orleans on federal Vioxx casesNewsday, NY - Jul 27, 2007… had thrown out as excessive for a retired FBI agent who won a lawsuit claiming the painkiller Vioxx caused his heart attack, the manufacturer contends. …
Read More…

Washington Post
Judge Expects Vioxx Stroke CasesWashington Post, United States - Jul 27, 2007By JANET McCONNAUGHEY AP NEW ORLEANS […]

Washington Post
Judge Expects Vioxx Stroke CasesWashington Post, United States - Jul 27, 2007By JANET McCONNAUGHEY AP NEW ORLEANS — Next year's federal Vioxx trials may focus on people who had strokes after taking the once popular painkiller, …
Read More…

Merck's Vioxx Under Fire AgainTheStreet.com - Jul 25, 2007By Robert Steyer A study published in the New England Journal […]

Washington Post - Nissen was one of the earliest critics of the arthritis drug Vioxx, which was withdrawn from the market in 2004 due to heart attack concerns, and he will be testifying at Monday’s meeting. Dr. Larry Deeb, president for medicine and science at the Read More
PRWeb - MedicineNet Survey […]

American Reporter - Jonathan Fishbein reported that bad faith in research resulted in deaths. Suppressed research could have stopped the Vioxx debacle. One Dallas jury was so enraged by bad faith in medicine at a Texas HMO that it awarded $366 million dollars to Dr Read More
Forbes - The excitement about […]

About - News & Issues
Study: Heart Risks Start Earlier for Arthritis Drug VioxxAbout - News & Issues, NY - Jul 26, 2007After arthritis drug Vioxx (rofecoxib) was removed from the market in September 2004, researchers suggested that there was an increased heart risk …
Read More…

Judge Expects Vioxx Stroke CasesTherapeutics Daily (subscription) (press release), PA - Jul 27, 200727, […]

Judge Expects Vioxx Stroke CasesTherapeutics Daily (subscription) (press release), PA - Jul 27, 200727, 2007 NEW ORLEANS_Next year's federal Vioxx trials may focus on people who had strokes after taking the once popular painkiller, the judge assigned to …
Read More…

Vioxx heart problems start early, study findsCTV.ca, Canada - Jul 25, 2007The heart problems associated with the painkiller Vioxx […]

St. Louis Post-Dispatch - The arthritis drug Vioxx was heavily advertised but later removed from the market because it increased the risk of heart attacks. There are hundreds of lawsuits pending about Vioxx. These ads force physicians to take time away from discussing other Read More
Philiy.com - Panelists with industry ties […]

CNNMoney.com
Vioxx study says risks begin earlierCNNMoney.com - Jul 25, 2007Although the median duration of treatment was only 7.4 months, the researchers concluded that Vioxx, known generically as rofecoxib, was still associated …
Read More…

Merck promotes lawyer to key global positionMSNBC - Jul 26, 2007Mr Frazier, 52, the architect of Merck's successful legal defence strategy for its withdrawn […]